mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.0032 |
0.9 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
mRNA |
palmostatin B |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
0.0032 |
0.9 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.9 |